MiR-155 Is a Liposarcoma Oncogene That Targets Casein Kinase-1α and Enhances β-Catenin SignalingPingyu Zhang, Dina Lev, Aviad Hoffman et al.|Cancer Research|2012Cited by 111
Uterine Leiomyosarcoma Management, Outcome, and Associated Molecular Biomarkers: A Single Institution’s ExperienceKristelle Lusby, Raphael E. Pollock, Chad J. Creighton et al.|Annals of Surgical Oncology|2013Cited by 78
Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine LeiomyosarcomaKari J. Brewer Savannah, Dina Lev, Markus PH. Ghadimi et al.|Clinical Cancer Research|2012Cited by 51